BioSpace News Archive

AIM Biotech has launched the idenTx 40 Plate, a high-throughput organ-on-a-chip system that lets researchers at biotechnology and pharmaceutical companies faithfully recreate the function of human organs and tissues without using animals for research.

Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the Evercore ISI 4th Annual HealthCONx Healthcare Conference virtually on Tuesday, November 30th, 2021 at 12:10PM Eastern Standard Time.

BlueJay, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, have entered a manufacturing agreement for BJT-778, one of BlueJay’s lead candidates.

EpiVax, Inc. announces the publication of three papers focusing on malaria vaccine efficacy, in collaboration with Leidos, the University of Georgia Center for Vaccines and Immunology, the University of Oxford’s Jenner Institute, and Sanofi Pasteur’s VaxDesign Campus.

Sirona Medical, a software company founded on a deep understanding of both the practice and business of radiology, today announced a partnership with RevealDx, a Seattle-based software developer focused on improving lung cancer outcomes through advanced, radiomics-based, clinical decision support.

Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, has partnered with Grant Hill, seven-time NBA All-Star and sports broadcaster, to launch Start Strong, a new initiative to help individuals make decisions with health in mind.

NRGene, an AI based genomic company operating in the agricultural industry, and Top Seeds International Ltd., a global seed company wholly owned by Mitsui & Co., Ltd., have signed a collaboration agreement to develop and commercialize new and improved cherry tomato varieties.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that its collaborator, Janssen Pharmaceuticals, Inc., (Janssen) one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has disclosed its collaboration with Arrowhead on investigational compound JNJ-75220795, which is in a Phase 1 clinical study.

Pressure BioSciences, Inc. reported financial results for the third quarter ended September 30, 2021, provided a business update, and offered guidance for an expected strong 2022.

Novavax, Inc. (Nasdaq: NVAX), today announced that European Medicines Agency (EMA) has begun its evaluation of an application for conditional marketing authorization (CMA) for Novavax’ COVID-19 vaccine, which will be marketed in the European Union under the brand name Nuvaxovid™.